NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 353 filers reported holding NATERA INC in Q4 2023. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $7,240 | +97.9% | 66,865 | +67.1% | 0.00% | +100.0% |
Q1 2024 | $3,659 | -35.4% | 40,013 | -55.8% | 0.00% | -50.0% |
Q4 2023 | $5,668 | +31.7% | 90,487 | -7.0% | 0.00% | -33.3% |
Q3 2023 | $4,303 | -22.5% | 97,259 | -14.8% | 0.00% | -25.0% |
Q2 2023 | $5,555 | -15.4% | 114,145 | -3.5% | 0.00% | +33.3% |
Q1 2023 | $6,570 | -63.5% | 118,322 | -73.6% | 0.00% | -62.5% |
Q4 2022 | $17,980 | -99.6% | 447,607 | +321.4% | 0.01% | +60.0% |
Q3 2022 | $4,655,000 | +376.0% | 106,211 | +285.1% | 0.01% | +400.0% |
Q2 2022 | $978,000 | +6.2% | 27,581 | +21.8% | 0.00% | 0.0% |
Q1 2022 | $921,000 | -73.4% | 22,653 | -38.8% | 0.00% | 0.0% |
Q4 2021 | $3,458,000 | +4.9% | 37,022 | +25.2% | 0.00% | 0.0% |
Q3 2021 | $3,298,000 | -42.2% | 29,580 | -41.2% | 0.00% | -66.7% |
Q2 2021 | $5,707,000 | -32.3% | 50,273 | -39.4% | 0.00% | -40.0% |
Q1 2021 | $8,425,000 | +135.3% | 82,978 | +130.6% | 0.01% | +150.0% |
Q4 2020 | $3,581,000 | -57.5% | 35,987 | -69.1% | 0.00% | -60.0% |
Q3 2020 | $8,426,000 | +321.3% | 116,639 | +190.6% | 0.01% | +150.0% |
Q2 2020 | $2,000,000 | +168.5% | 40,132 | +60.9% | 0.00% | +100.0% |
Q1 2020 | $745,000 | -69.4% | 24,942 | -65.4% | 0.00% | 0.0% |
Q4 2019 | $2,431,000 | +104.6% | 72,167 | +99.4% | 0.00% | 0.0% |
Q3 2019 | $1,188,000 | +19.4% | 36,188 | +0.3% | 0.00% | 0.0% |
Q2 2019 | $995,000 | +142.7% | 36,077 | +81.6% | 0.00% | – |
Q1 2019 | $410,000 | -64.0% | 19,863 | -75.7% | 0.00% | -100.0% |
Q4 2018 | $1,140,000 | +160.9% | 81,640 | +347.0% | 0.00% | – |
Q3 2018 | $437,000 | +20.4% | 18,266 | -5.5% | 0.00% | – |
Q2 2018 | $363,000 | +131.2% | 19,328 | +13.9% | 0.00% | – |
Q1 2018 | $157,000 | +18.9% | 16,974 | +15.7% | 0.00% | – |
Q4 2017 | $132,000 | -50.2% | 14,665 | -28.5% | 0.00% | – |
Q3 2017 | $265,000 | +3212.5% | 20,503 | +2587.2% | 0.00% | – |
Q2 2017 | $8,000 | -76.5% | 763 | -80.0% | 0.00% | – |
Q1 2017 | $34,000 | +240.0% | 3,820 | +367.6% | 0.00% | – |
Q4 2016 | $10,000 | +100.0% | 817 | +70.9% | 0.00% | – |
Q3 2016 | $5,000 | – | 478 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 503,094 | $54,480,049 | 52.98% |
Kynam Capital Management, LP | 2,014,408 | $218,140,242 | 16.83% |
Eagle Health Investments LP | 474,114 | $51,341,805 | 9.00% |
Sofinnova Investments, Inc. | 1,550,280 | $167,879,821 | 8.72% |
Eversept Partners, LP | 1,173,494 | $127,077,665 | 8.70% |
Lagoda Investment Management, L.P. | 130,195 | $14,098,817 | 8.11% |
Duquesne Family Office | 1,974,880 | $213,860 | 7.33% |
Tri Locum Partners LP | 230,585 | $24,970,050 | 6.31% |
PERKINS CAPITAL MANAGEMENT INC | 57,550 | $6,232 | 5.87% |
PURA VIDA INVESTMENTS, LLC | 67,500 | $7,309,575 | 4.63% |